An observational cross sectional cohort study to estimate the frequency of hepatitis E virus (HEV) infection in neurological disease of inflammatory/ immune mediated origin and ischemic stroke
Completed
- Conditions
- post infectious nervous system diseasespost-infectious neurological diseases1004743810034606
- Registration Number
- NL-OMON42390
- Lead Sponsor
- Jeroen Bosch Ziekenhuis
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 100
Inclusion Criteria
Participant is willing and able to give informed consent for participation in the study.
Male or Female, aged 18 years or above.
Diagnosed with an (sub)acute post-infectious/ immune-mediated neurological disorder or ischemic stroke
Participants will have blood drawn for standard clinical care.
Exclusion Criteria
-Not willing and able to give informed consent
Study & Design
- Study Type
- Observational invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The number of HEV positive neurological patients (HEV PCR positive and/or IgM<br /><br>positive.</p><br>
- Secondary Outcome Measures
Name Time Method <p>To describe in detail the phenotypes of neurological illness of patients with a<br /><br>recent HEV infection.</p><br>